Cold Atmospheric Plasma‐Activated Decellularized Extracellular Matrix Gel as a Tumor‐Infiltrating Immunoactivation Platform for Post‐Surgical Cancer Immunotherapy (Adv. Mater. 34/2026)

Cold Atmospheric Plasma-Activated Decellularized Extracellular Matrix Gel A pseudo-colored scanning electron micrograph (original data) showcasing the intricate architecture of an injectable, plasma-activated decellularized tumor extracellular matrix (CAP-DECM) hydrogel. The image highlights the hydrogel's capacity to recruit tumor cells (highlighted in red), transforming the post-operative environment into a localized, immune-activating niche designed to prevent cancer recurrence. More details can be found in the Research Article by Guojun Chen and co-workers (DOI: 10.1002/adma.202515444).